These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28457471)

  • 1. Response to Omalizumab in Solar Urticaria: Report of 3 Cases.
    Rodríguez-Jiménez P; Chicharro P; Pérez-Plaza A; de Argila D
    Actas Dermosifiliogr; 2017 Oct; 108(8):e53-e55. PubMed ID: 28457471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria.
    Arasi S; Crisafulli G; Caminiti L; Guarneri F; Aversa T; Porcaro F; Pajno GB
    Pediatr Allergy Immunol; 2015 Sep; 26(6):583-5. PubMed ID: 26033828
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful omalizumab treatment of severe solar urticaria in a 6-year-old child.
    Levi A; Tal Y; Dranitzki Z; Shalit M; Enk CD
    Pediatr Allergy Immunol; 2015 Sep; 26(6):588-90. PubMed ID: 26172942
    [No Abstract]   [Full Text] [Related]  

  • 4. Incapacitating solar urticaria: successful treatment with omalizumab.
    Kieselova K; Santiago F; Henrique M
    An Bras Dermatol; 2019 Jul; 94(3):331-333. PubMed ID: 31365663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Partial response of solar urticaria to omalizumab therapy].
    Kowalzick L; Thiel W; C Bielfeld ; Ziegler H; Eickenscheidt L
    Hautarzt; 2017 Jun; 68(6):492-496. PubMed ID: 27995273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solar urticaria induced by visible light: successful treatment with omalizumab.
    Terrani I; Bircher AJ; Scherer Hofmeier K
    Clin Exp Dermatol; 2016 Dec; 41(8):890-892. PubMed ID: 27766671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solar urticaria caused by visible light in a 33-year-old male refractory to treatment with omalizumab.
    Wright E; Kurland E; Lim HW
    Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):316-317. PubMed ID: 32141097
    [No Abstract]   [Full Text] [Related]  

  • 8. Long term treatment with omalizumab in adolescent with refractory solar urticaria.
    Iannelli M; Passanisi S; Crisafulli G; Arasi S; Caminiti L; Zirilli G; Pajno GB
    Ital J Pediatr; 2021 Sep; 47(1):195. PubMed ID: 34583772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solar urticaria. A report of 25 cases and difficulties in phototesting.
    Ryckaert S; Roelandts R
    Arch Dermatol; 1998 Jan; 134(1):71-4. PubMed ID: 9449912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Solar urticaria. Case report and literature review].
    Raigosa M; Toro Y; Sánchez J
    Rev Alerg Mex; 2017; 64(3):371-375. PubMed ID: 29046033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamines: an expert opinion.
    Vestergaard C; Toubi E; Maurer M; Triggiani M; Ballmer-Weber B; Marsland A; Ferrer M; Knulst A; Giménez-Arnau A
    Eur J Dermatol; 2017 Feb; 27(1):10-19. PubMed ID: 27882879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial improvement of solar urticaria after omalizumab.
    Waibel KH; Reese DA; Hamilton RG; Devillez RL
    J Allergy Clin Immunol; 2010 Feb; 125(2):490-1. PubMed ID: 20159260
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Omalizumab changed my life': a patient perspective on solar urticaria.
    Parkin D; Ling TC; Ayer J; Rhodes LE; Rutter KJ
    Clin Exp Dermatol; 2024 Jul; 49(8):935-936. PubMed ID: 38491908
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omalizumab in the Treatment of Chronic Inducible Urticaria.
    Chicharro P; Rodríguez P; de Argila D
    Actas Dermosifiliogr; 2017 Jun; 108(5):423-431. PubMed ID: 27717421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature.
    Snast I; Kremer N; Lapidoth M; Enk CD; Tal Y; Rosman Y; Confino-Cohen R; Hodak E; Levi A
    J Allergy Clin Immunol Pract; 2018; 6(4):1198-1204.e3. PubMed ID: 29572192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solar Urticaria and Omalizumab: A Retrospective Case-Control Study and Follow-Up.
    Casanova-Esquembre A; Lorca-Spröhnle J; Peñuelas-Leal R; Pérez-Ferriols A
    Actas Dermosifiliogr; 2024 Oct; 115(9):T931-T932. PubMed ID: 38925450
    [No Abstract]   [Full Text] [Related]  

  • 18. Solar Urticaria and Omalizumab: A Retrospective Case-Control Study and Follow-Up.
    Casanova-Esquembre A; Lorca-Spröhnle J; Peñuelas-Leal R; Pérez-Ferriols A
    Actas Dermosifiliogr; 2024 Oct; 115(9):931-932. PubMed ID: 38452893
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluating patient responses to omalizumab in solar urticaria.
    Griffin LL; Haylett AK; Rhodes LE
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):57-65. PubMed ID: 30338865
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria.
    Silva PM; Costa AC; Mendes A; Barbosa MP
    Allergol Immunopathol (Madr); 2015; 43(2):168-73. PubMed ID: 24731771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.